Technical Analysis for CPIX - Cumberland Pharmaceuticals Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical CPIX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| 200 DMA Resistance | Bearish | -1.60% | |
| 20 DMA Resistance | Bearish | -1.60% | |
| Pocket Pivot | Bullish Swing Setup | -1.60% | |
| Outside Day | Range Expansion | -1.60% | |
| 20 DMA Resistance | Bearish | 1.99% | |
| Gapped Down | Weakness | 1.99% | |
| Fell Below 200 DMA | Bearish | -3.15% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Gapped Down (Full) | 3 days ago |
| 10 DMA Resistance | 3 days ago |
| Down 3% | 3 days ago |
| Down 2 % | 3 days ago |
| Down 1% | 3 days ago |
Get a Trading Assistant
- Earnings date: 05/18/2021
Cumberland Pharmaceuticals Inc. Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Clinical Development Pain Drugs Medication Nashville Gastroenterology Analgesics Hepatotoxins Fever Constipation Prescription Product Prescription Products Paracetamol Hepatorenal Syndrome Ibuprofen Treatment Of Hepatorenal Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.14 |
| 52 Week Low | 2.77 |
| Average Volume | 68,490 |
| 200-Day Moving Average | 3.19 |
| 50-Day Moving Average | 3.26 |
| 20-Day Moving Average | 3.14 |
| 10-Day Moving Average | 3.11 |
| Average True Range | 0.12 |
| ADX | 12.54 |
| +DI | 19.59 |
| -DI | 20.21 |
| Chandelier Exit (Long, 3 ATRs ) | 3.03 |
| Chandelier Exit (Short, 3 ATRs ) | 3.37 |
| Upper Bollinger Band | 3.30 |
| Lower Bollinger Band | 2.98 |
| Percent B (%b) | 0.27 |
| BandWidth | 10.21 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.04 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.20 | ||||
| Resistance 3 (R3) | 3.21 | 3.18 | 3.18 | ||
| Resistance 2 (R2) | 3.18 | 3.14 | 3.17 | 3.17 | |
| Resistance 1 (R1) | 3.12 | 3.12 | 3.11 | 3.11 | 3.16 |
| Pivot Point | 3.09 | 3.09 | 3.08 | 3.09 | 3.09 |
| Support 1 (S1) | 3.04 | 3.06 | 3.02 | 3.03 | 2.98 |
| Support 2 (S2) | 3.01 | 3.04 | 3.00 | 2.97 | |
| Support 3 (S3) | 2.95 | 3.01 | 2.96 | ||
| Support 4 (S4) | 2.94 |
